TheraRadar
Landscape → Dermatology

Alopecia Clinical Trial Landscape

Data updated: May 20, 2026

251 clinical trials tracked since 2008

Alopecia is being studied across 251 clinical trials registered since 2008, with 77 programs currently active. The competitive pipeline includes 25 active Phase 3 trials, 40 active Phase 2 trials, and 18 active Phase 1 trials. Top industry sponsors include Applied Biology, Inc., Veradermics, Inc., Pfizer.

77 active
/
251 total (since 2008)
18
Phase 1 Active
54 total
40
Phase 2 Active
143 total
25
Phase 3 Active
62 total
9
Phase 4 Active
23 total

Top Industry Sponsors

Sorted by active Active Done Failed
Applied Biology, Inc. 4 0 1
Veradermics, Inc. 4 0 0
Pfizer 3 5 1
AbbVie 2 7 1
Eli Lilly 2 2 0

+ 10 more sponsors — see full table below

Featured Phase 3 Trials

NCT06873945 ACTIVE NOT RECRUITING
A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata
Pfizer n=550
NCT06012240 RECRUITING
A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
AbbVie n=1,500
NCT05888922 RECRUITING
Evaluation of Efficacy and Safety of Oral Minoxidil 1 mg in Female Androgenetic Alopecia
Industrial Farmacéutica Cantabria, S.A. n=520
NCT07029828 RECRUITING
A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.
Pfizer n=140
NCT05723198 RECRUITING
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
Eli Lilly and Company n=595

+ 57 more Phase 3 trials — see full database below

Alopecia — Trials Started by Year (last 10 years)

2016
15
2017
6
2018
15
2019
13
2020
13
2021
15
2022
23
2023
22
2024
19
2025
32
2026
20

TheraRadar.com

Full Trial Database

Complete sponsor table, every trial across all phases, plus competitive analytics. Sortable, filterable, exportable for Pro users.

Top Sponsors (all-time)

Applied Biology, Inc.
5
Veradermics, Inc.
4
Pfizer
9
AbbVie
10
Eli Lilly
4
Eurofarma Laboratorios S.A.
3
Sun Pharmaceutical Industries, Inc.
3
Suzhou Kintor Pharmaceutical Inc,
8
Chong Kun Dang Pharmaceutical
4
Cassiopea SpA
2

Active Trials by Phase

Phase 1
18
Phase 2
40
Phase 3
25
Phase 4
9

Enrollment Size Distribution

1-50
103
51-200
88
201-500
28
501-1k
16
1k+
3

All Industry Sponsors

Sorted by active Active Done Failed
Applied Biology, Inc. 4 0 1
Veradermics, Inc. 4 0 0
Pfizer 3 5 1
AbbVie 2 7 1
Eli Lilly 2 2 0
Eurofarma Laboratorios S.A. 2 1 0
Sun Pharmaceutical Industries, Inc. 2 1 0
Suzhou Kintor Pharmaceutical Inc, 1 7 0
Chong Kun Dang Pharmaceutical 1 3 0
Cassiopea SpA 1 1 0
Industrial Farmacéutica Cantabria, S.A. 1 0 0
Dren Bio 1 0 0
Absci Pty Ltd. 1 0 0
Q32 Bio Inc. 1 0 0
Innovent Biologics (Suzhou) Co. Ltd. 1 0 0
NCT06873945 ACTIVE NOT RECRUITING
A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata
Pfizer n=550
NCT06012240 RECRUITING
A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
AbbVie n=1,500
NCT05888922 RECRUITING
Evaluation of Efficacy and Safety of Oral Minoxidil 1 mg in Female Androgenetic Alopecia
Industrial Farmacéutica Cantabria, S.A. n=520
NCT07029828 RECRUITING
A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.
Pfizer n=140
NCT05723198 RECRUITING
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
Eli Lilly and Company n=595
NCT07529977 NOT YET RECRUITING
Phase 3 Study to Evaluate the Efficacy and Safety of Oral Minoxidil (N1087) in Men With Androgenetic Alopecia.
Eurofarma Laboratorios S.A. n=372
NCT07516561 NOT YET RECRUITING
Efficacy and Safety of APSMNF in the Treatment of Male Androgenetic Alopecia
Apsen Farmaceutica S.A. n=336
NCT06648850 NOT YET RECRUITING
Clinical Study of DA-001 as a Treatment for Hair Shedding Reduction and Hair Re-Growth
Applied Biology, Inc. n=1,120
NCT07029711 RECRUITING
A Study to Learn About Medicine Called Ritlecitinib in Children Aged Between 6 to 12 Years With Severe Alopecia Areata
Pfizer n=225
NCT05910450 ACTIVE NOT RECRUITING
A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss
Cassiopea SpA n=703
NCT07435012 RECRUITING
Androgenic Alopecia TH07 Clinical Trial
Triple Hair Inc n=420
NCT07080931 RECRUITING
Efficacy and Safety of 5% Minoxidil Foam in Female Androgenetic Alopecia
Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd. n=294
NCT06972264 ACTIVE NOT RECRUITING
Safety and Efficacy of VDPHL01 in Males With AGA
Veradermics, Inc. n=480
NCT07133308 RECRUITING
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
Sun Pharmaceutical Industries, Inc. n=355
NCT07303322 NOT YET RECRUITING
Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of N1087 in Participants With Female Pattern Hair Loss (MINORA-WOMEN)
Eurofarma Laboratorios S.A. n=372
NCT07023302 RECRUITING
A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants in Japan With Alopecia Areata
AbbVie n=123
NCT07273799 NOT YET RECRUITING
Comparison of Outcomes Between Topical Minoxidil Versus Oral Minoxidil for the Treatment of Androgenetic Alopecia
Sheikh Zayed Federal Postgraduate Medical Institute n=200
NCT04594018 RECRUITING
Efficacy and Safety of Finlândia Hair Lotion Association on Androgenetic Alopecia
EMS n=190
NCT07146022 RECRUITING
Safety and Efficacy of VDPHL01 in Females With Androgenetic Alopecia (AGA)
Veradermics, Inc. n=552
NCT06724614 ACTIVE NOT RECRUITING
Efficacy and Safety of VDPHL01 in Males With AGA
Veradermics, Inc. n=480
NCT03898479 ACTIVE NOT RECRUITING
Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata
Sun Pharmaceutical Industries, Inc. n=1,000
NCT06762548 NOT YET RECRUITING
Clinical Study of DA-007 for the Treatment of Chemotherapy Induced Alopecia
Applied Biology, Inc. n=140
NCT06916793 NOT YET RECRUITING
A Phase 3 Study to Evaluate the Safety and Efficacy of CKD-843 in Male Patients With Androgenetic Alopecia
Chong Kun Dang Pharmaceutical n=288
NCT06501924 NOT YET RECRUITING
Clinical Study of DA-002 and DA-005 As a Treatment for Hair Loss
Applied Biology, Inc. n=516
NCT06622824 NOT YET RECRUITING
To Evaluate Efficacy and Safety of TopicalKX-826 Solution in Chinese Male Patients With Androgenetic Alopecia
Suzhou Kintor Pharmaceutical Inc, n=756
NCT06924632 COMPLETED
Efficacy & Safety of Minoxidil SL Tablets in Men With AGA
Samson Clinical Operations Pty Ltd n=142
NCT03570749 COMPLETED
A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata
Eli Lilly and Company n=784
NCT04006457 COMPLETED
Long-Term PF-06651600 for the Treatment of Alopecia Areata
Pfizer n=1,057
NCT03899259 COMPLETED
A Study of Baricitinib (LY3009104) in Adults With Severe or Very Severe Alopecia Areata
Eli Lilly and Company n=606
NCT02557074 COMPLETED
TREg Activation in the Treatment of the PELADE (Alopecia Areata)
Centre Hospitalier Universitaire de Nice n=44
NCT03651752 TERMINATED
DPCP for the Treatment of Alopecia Areata
University of Minnesota n=4
NCT05914805 COMPLETED
A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss (SCALP2)
Cassiopea SpA n=762
NCT05041803 COMPLETED
European Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata
Sun Pharmaceutical Industries, Inc. n=407
NCT06539273 COMPLETED
Exosome Treatment in Androgenetic Alopecia
Yeditepe University Hospital n=30
NCT05255237 COMPLETED
Extension Study to Evaluate Safety and Efficacy of Jaktinib in Adults With Alopecia Areata
Suzhou Zelgen Biopharmaceuticals Co.,Ltd n=315
NCT05051761 COMPLETED
Study to Evaluate the Safety and Efficacy of Jaktinib in Adults With Alopecia Areata
Suzhou Zelgen Biopharmaceuticals Co.,Ltd n=425
NCT04721548 COMPLETED
Treatment of Androgenetic Alopecia in Men for 24 Weeks
Eurofarma Laboratorios S.A. n=336
NCT06484881 WITHDRAWN
Clinical Study of Probiotic Treatment for Androgenetic Alopecia
Applied Biology, Inc.
NCT06278402 COMPLETED
Efficacy of Oral Tofacitinib in Moderate to Severe Alopecia Areata, Totalis and Universalis at Tertiary Care Hospital, Karachi.
Jinnah Hospital n=30
NCT03240627 COMPLETED
Efficacy and Safety of LH-8 in Paediatric Alopecia Areata
Legacy Healthcare SA n=107
NCT05989165 COMPLETED
Effectiveness of Combination Therapy of Microneedling and Minoxidil in Androgenetic Alopecia of Indonesian Men
Indonesia University n=36
NCT04825561 COMPLETED
A Study to Evaluate the Efficacy and Safety of AD-208
Addpharma Inc. n=139
NCT04797650 COMPLETED
Study to Evaluate the Efficacy and Safety of CTP-543 in Adults With Moderate to Severe Alopecia Areata (THRIVE-AA2)
Concert Pharmaceuticals n=517
NCT04518995 COMPLETED
Study to Evaluate the Efficacy and Safety of CTP-543 in Adults With Moderate to Severe Alopecia Areata (THRIVE-AA1)
Concert Pharmaceuticals n=706
NCT04481412 COMPLETED
Topical Cetirizine in Androgenetic Alopecia in Females
Cairo University n=66
NCT05296863 COMPLETED
Adipose-derived Stem Cell Conditioned Media as a Novel Approach for Hair Regrowth in Male Androgenetic Alopecia
Dr. dr. Lili Legiawati, SpKK(K) n=37
NCT03732807 COMPLETED
PF-06651600 for the Treatment of Alopecia Areata
Pfizer n=718
NCT03742518 COMPLETED
A Study Evaluating the Efficacy and Safety of SM04554 Topical Solution in Male Subjects With Androgenetic Alopecia
Biosplice Therapeutics, Inc. n=675
NCT04249128 COMPLETED
Nourishing Hair, Skin & Nails Supplement Study (Derm Aid)
ProofPilot n=75
NCT03753113 COMPLETED
Evaluating the Topical Herbal Solution on the Treatment of Male Pattern Hair Loss and Comparison With Minoxidil 5%
Farid Masoud n=24
NCT03004469 COMPLETED
Study to Evaluate the Efficacy and Safety of P-3074 Topical Solution in the Treatment of Androgenetic Alopecia
Polichem S.A. n=458
NCT02014584 COMPLETED
Sexual Function in Men Receiving Dutasteride for Androgenetic Alopecia
Stiefel, a GSK Company n=117
NCT01231607 COMPLETED
Dutasteride Versus Placebo and Finasteride in Men With Androgenetic Alopecia
GlaxoSmithKline n=917
NCT01831791 COMPLETED
A Long-term Study to Determine Safety and Efficacy of Dutasteride in Male Subjects With Androgenetic Alopecia
GlaxoSmithKline n=120
NCT02037191 COMPLETED
The Efficiency Of The Methotrexate At Patients Affected By Grave Pelade
University Hospital, Rouen n=90
NCT02691117 TERMINATED
Topical Garlic Concentrate for Alopecia Areata in Children
Elena Pope n=8
NCT01590238 COMPLETED
Enhancing Hair Density With Platelet Rich Fibrin Matrix (PRFM)
The New York Eye & Ear Infirmary n=15
NCT01226459 COMPLETED
Clinical Trial in Females for Female Pattern Hair Loss
Johnson & Johnson Healthcare Products Division of McNEIL-PPC, Inc. n=404
NCT01145625 COMPLETED
Clinical Trial in Females With Female Pattern Hair Loss
Johnson & Johnson Healthcare Products Division of McNEIL-PPC, Inc. n=322
NCT00997815 COMPLETED
The Randomized Double-blind Placebo-controlled Trial of Intralesional Botulinum Toxin A Injection for Recalcitrant Alopecia Totalis and Alopecia Universalis
Siriraj Hospital n=20
NCT01391156 COMPLETED
Efficacy Study of Minoxidil Lotion Versus Combined Minoxidil and Finasteride Lotion to Treat Male Pattern Hair Loss
Mae Fah Luang University Hospital n=40
NCT00958750 COMPLETED
Efficacy and Safety Study to Compare Two Minoxidil Formulations on Women With Androgenetic Alopecia
Charite University, Berlin, Germany n=113

Full Alopecia Pipeline

Every sponsor, every trial across Phase 1–4. Sortable, filterable, exportable.

Unlock with Pro

Data: ClinicalTrials.gov · Trials registered 2008 onwards · Industry sponsors only